KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $10.1 million.

  • Bionano Genomics' Cash from Financing Activities rose 6734.76% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.3 million, marking a year-over-year decrease of 4828.81%. This contributed to the annual value of -$13.7 million for FY2024, which is 11202.39% down from last year.
  • As of Q3 2025, Bionano Genomics' Cash from Financing Activities stood at $10.1 million, which was up 6734.76% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Cash from Financing Activities ranged from a high of $337.5 million in Q1 2021 and a low of -$21.6 million during Q1 2024
  • Moreover, its 5-year median value for Cash from Financing Activities was $6.0 million (2024), whereas its average is $25.4 million.
  • In the last 5 years, Bionano Genomics' Cash from Financing Activities skyrocketed by 21221428.57% in 2023 and then tumbled by 24545.82% in 2024.
  • Over the past 5 years, Bionano Genomics' Cash from Financing Activities (Quarter) stood at $2.0 million in 2021, then tumbled by 92.58% to $146000.0 in 2022, then soared by 46806.85% to $68.5 million in 2023, then crashed by 94.32% to $3.9 million in 2024, then surged by 159.02% to $10.1 million in 2025.
  • Its Cash from Financing Activities stands at $10.1 million for Q3 2025, versus $1.5 million for Q2 2025 and $10.9 million for Q1 2025.